Time

Event

8:55 am – Roof

Welcome Back
* Sara Jane Demy, Founder & CEO, Demy-Colton

9:00 am – Roof

“Big Think" Plenary Session

* Susan Hockfield, PhD, Professor, Neuroscience & President Emerita, MIT
* Nabiha Saklayen, PhD, CEO & Co-Founder, Cellino

10:00 am – 12th Floor

One-to-One Meetings

10:00 am – 2nd Floor

Presenting Companies

11:00 am – 12th Floor

Dialogue 6A 
Real Use of AI in Pharma: Today and in the Near Future

Moderator: David Schull, President, Russo Partners

Panel:
* Friso Postma, VP, Artificial Intelligence Drug Discovery, BioXcel Therapeutics

11:00 am – Rooftop

Dialogue 6B 
Emerging Technologies and Approaches in Cell & Gene Therapy
As the field of cell and gene therapy rapidly evolves, novel technologies and innovative approaches like AI/ML are pushing the boundaries of what’s possible. Experts will discuss how emerging technologies are overcoming current limitations, improving precision, and accelerating the path from research to clinical application to pave the way for more effective and accessible cell and gene therapies.

Moderator:
Lei Lei Wu, News Reporter, Endpoints News 

Panel:
* Paul Bresge, CEO, Ray Therapeutics 
* Michael Roberts, PhD, CEO, Adaptin Bio
* Kate Rochlin, PhD, COO, IN8bio
* Lexi Rovner, CEO, 64x Bio

12:00 pm – 2nd Floor

BioGENEius Award

12:10 pm – 2nd Floor

“Big Think” Plenary Session
Alternative Financing: Seeds of Creativity

Moderator: Steve Brozak, DMH, Managing Partner & President, WBB Securities

Panel:
* Rick Bright, PhD, Pandemic Prevention & Response
* George Santo, Head, Northeast Life Sciences, J.P. Morgan
* Joseph Shonkwiler, MD, COO, Advanced Research Projects Agency for Health (ARPA-H)

1:10 pm – 12th Floor

Luncheon

2:00 pm – 12th Floor

One-to-One Meetings

2:00 pm – 12th Floor

Dialogue 7A
Cardiovascular Disease: A Major Comorbidity of Obesity Impacting Individuals and Healthcare Systems
The obesity epidemic has reached critical levels today. By 2050, an estimated that 180 million adults will be living with obesity. This epidemic will significantly increase the risk of cardiovascular disease (CVD) for individuals. Not only that, but it will also become a major burden on the healthcare system.

* Minji Kim, PhD, Chief Business Officer, Mineralys Therapeutics

2:00 pm – Rooftop

Dialogue 7B 
The Future of Human Immunome

Moderator: David Ewing Duncan, Journalist, Author, Researcher

3:00 pm – 12th Floor

Dialogue 8A 

Women’s Health

Moderator: Matthew Arnold, Principal Analyst & Content Strategist, Clarivate

3:00 pm – Rooftop

Dialogue 8B

The Future of Pb-based Radiopharmaceuticals: Why Lead-Based Isotopes Will Play a Major Role in Precision Medicine

Moderator: Jeff Bockman, PhD, Expert Advisor, Executive Vice President, Oncology, Lumanity

Panel:
* Thijs Spoor, CEO, Perspective Therapeutics

4:00 pm – 2nd Floor

Closing “Big Think” Plenary Session
Heard Around the Street: What’s Buzzing in Biotech

Moderator: Kimberly Ha, Founder & CEO, KKH Advisors

Panel:
* Max Bayer, Pharma Reporter, Endpoints News
* Sony Salzman, Coordinating Producer, Medical Unit, ABC News
* Uduak Thomas, Senior Editor, Genetic Engineering & Biotechnology News

5:00 pm – Rooftop

Evening Reception